Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simple steps to diagnosis at primary care centres

S Noltorp1, C G Gottfries, N Nörgaard

  • 1Delfinen and Sjöcrona, Care Centres, Höganäs Sweden.

International Clinical Psychopharmacology
|November 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HUMAN BRAIN LEVELS OF MONOAMINES AND THEIR METABOLITES. POSTMORTEM INVESTIGATIONS.

Acta psychiatrica Scandinavica·2017
Same author

Clinical and neurochemical aspects of diseases with cognitive impairment.

Reviews in the neurosciences·2011
Same author

Transmitter deficits in Alzheimer's disease.

Neurochemistry international·2010
Same author

Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales.

Annals of the rheumatic diseases·2005
Same author

Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2004
Same author

Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment.

Dementia and geriatric cognitive disorders·2003

Depression affects 12.9% of elderly patients in primary care, often going undiagnosed. The Geriatric Depression Scale (GDS-20) is a valuable tool for identifying depression in this population.

Area of Science:

  • Geriatric Medicine
  • Psychiatry
  • Primary Care Research

Background:

  • Depression prevalence in the elderly varies, often reported between 12-15%.
  • Underdiagnosis of depression is a significant issue in primary care settings for older adults.
  • Screening tools are essential for identifying depression in elderly populations.

Purpose of the Study:

  • To assess the prevalence of affective disorders in elderly patients attending primary care centers.
  • To evaluate the utility of the Swedish version of the Geriatric Depression Scale (GDS-20) as a screening instrument.
  • To determine the feasibility and acceptance of the GDS-20 among primary care physicians.

Main Methods:

  • A 3-month study involving 1189 patients from two primary care centers.

Related Experiment Videos

  • Utilized the Swedish version of the Geriatric Depression Scale (GDS-20) for screening.
  • 1002 patients were assessed, and their data analyzed for affective disorders.

    • Main Results:

    • 12.9% of the assessed elderly patients were found to suffer from affective disorders.
    • The Geriatric Depression Scale (GDS-20) proved effective in identifying patients with depression.
    • Participating physicians found the GDS-20 easy to use and recommended its widespread adoption.

    Conclusions:

    • Depression is significantly underdiagnosed in elderly patients within primary care.
    • The GDS-20 is a valuable and user-friendly screening tool for detecting depression in older adults.
    • Routine use of the GDS-20 in primary care centers is recommended to improve depression identification and management.